Kerry Corrigan

Cooley advised EyeBiotech Limited, a privately held, clinical-stage ophthalmology biotechnology company working to deliver a new generation of therapies for eye diseases, on the close of an extension to its Series A financing, bringing the total raised to date to $130 million.

Cooley advised Snyk, a leader in developer security, on its acquisition of Enso Security, pioneers of the industry’s first application security posture management (ASPM) solution.

Cooley advised Snyk, a cybersecurity software startup, on its $530 million Series F financing, which brings the company’s valuation to $8.5 billion. Lawyers Ryan Naftulin, Kerry Corrigan and Mark Jones led the Cooley team advising Snyk.